BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villeret B, Solhonne B, Straube M, Lemaire F, Cazes A, Garcia-Verdugo I, Sallenave JM. Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience. Front Immunol 2020;11:117. [PMID: 32117268 DOI: 10.3389/fimmu.2020.00117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Seldeslachts L, Vanderbeke L, Fremau A, Reséndiz-Sharpe A, Jacobs C, Laeveren B, Ostyn T, Naesens L, Brock M, Van De Veerdonk FL, Humblet-Baron S, Verbeken E, Lagrou K, Wauters J, Vande Velde G. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model. Virulence 2021;12:2493-508. [PMID: 34546839 DOI: 10.1080/21505594.2021.1974327] [Reference Citation Analysis]
2 Cendra MDM, Torrents E. Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnol Adv 2021;49:107734. [PMID: 33785375 DOI: 10.1016/j.biotechadv.2021.107734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sallenave JM, Guillot L. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? Front Immunol 2020;11:1229. [PMID: 32574272 DOI: 10.3389/fimmu.2020.01229] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 27.0] [Reference Citation Analysis]
4 Johansson C, Kirsebom FCM. Neutrophils in respiratory viral infections. Mucosal Immunol 2021;14:815-27. [PMID: 33758367 DOI: 10.1038/s41385-021-00397-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, Shlomai A, Goldberg E, Sklan EH. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep 2021;11:12703. [PMID: 34135459 DOI: 10.1038/s41598-021-92220-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Cipolla EM, Huckestein BR, Alcorn JF. Influenza sequelae: from immune modulation to persistent alveolitis. Clin Sci (Lond) 2020;134:1697-714. [PMID: 32648583 DOI: 10.1042/CS20200050] [Reference Citation Analysis]
7 Riquelme SA, Prince A. Airway immunometabolites fuel Pseudomonas aeruginosa infection. Respir Res 2020;21:326. [PMID: 33302964 DOI: 10.1186/s12931-020-01591-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Dong C, Shen F, Dong H, Dong L, Fu Y, Xu Y, Ning J. Community-acquired Pseudomonas aeruginosa pneumonia manifested by bloody pleural effusion in a previously healthy infant: A case report. J Clin Lab Anal 2022;:e24466. [PMID: 35561264 DOI: 10.1002/jcla.24466] [Reference Citation Analysis]